Events Conference Coverage

Latest news in Conference Coverage

Coverage of the 2025 Face to Face Drug Plan Management Forum

Running for 20 years, Benefits Canada’s 2025 Face to Face Drug Plan Management Forum is the industry’s most popular drug benefits conference. This year, attendees…

2025 Face to Face Drug Plan Management Forum: Panel: Drug plan experts call for balance between cost and value

As the drug plan landscape evolves, the nuanced tension between cost management and the imperative to support employee health continues, according to a panel of…

2025 Face to Face Drug Plan Management Forum: Preserving private drug plan coverage in Canada

As Canada navigates the evolving drug coverage landscape, private drug plans remain a cornerstone of access, innovation and economic growth. Indeed, private drug plans are…

2025 Face to Face Drug Plan Management Forum: The rising impact of chronic skin conditions on drug plans

As dermatological treatments move up the ranking of conditions with the highest paid drug claims, they’ve become increasingly significant for private drug plan sponsors, according…

2025 Face to Face Drug Plan Management Forum: Navigating coverage challenges for GLP-1 drugs beyond weight management

A single drug can be approved for multiple conditions, but each new use requires its own clinical trials and regulatory approval, even if the drug…

2025 Face to Face Drug Plan Management Forum: Pharmacy benefit managers delivering ‘operational backbone’ in drug plan management

Pharmacy benefit managers in Canada have undergone a significant transformation over the years, said Akhil Pandit Pautra, senior manager of clinical services, health claims administration…

2025 Face to Face Drug Plan Management Forum: Closing the gap between vaccines and health benefits plans

“Immunization is one of the best investments money can buy, according to the World Health Organization,” said Johnny Ma, president at Mapol Inc., during a…

2025 Face to Face Drug Plan Management Forum: Multiple medication options leads to better outcomes for migraine patients

Although many medications may seem alike, in the management of chronic conditions, it’s crucial to have access to a broad selection of treatment options to…

2025 Face to Face Drug Plan Management Forum: Employers urged to champion cancer support in the workplace

For Jocelyn Laidlaw, a former anchor at CTV News, a sudden diagnosis of stage 3A metastatic colorectal cancer revealed not only the emotional toll of…

Coverage of the 2025 Investment Innovation Conference

With only a few weeks left in a year impacted by trade wars, equity concentration risk and the increased appeal of artificial intelligence opportunities, defined…

2025 Investment Innovation Conference: Where does Canada fit in an era of anti-globalization?

The current moment is rooted in shifting ideas, characterized by the rise and fall of globalization, said Sean Speer, editor-at-large at the Hub and a…

2025 Investment Innovation Conference: Global uncertainty pushing emerging markets debt as alternative funding source

Fading developed markets bilateral aid and U.S. tariff policy is pushing emerging markets debt as an attractive alternative for growing countries, according to Yvette Babb,…

2025 Investment Innovation Conference: Systematic and quantitative processes unlocking new path for fixed income asset management

A quantitative investment process could begin competing with the best fixed income and fundamental traditional credit asset managers in the near future, according to Bernd…

2025 Investment Innovation Conference: Institutional investor demand for alternative debt assets up in CLO market

The size of the collateralized loan obligation market is revealing an interest pattern in alternative debt investment opportunities, particularly in Europe and the U.S., according…

2025 Investment Innovation Conference: How CPP Investments is balancing innovation and stability

CPP Investments’ chief executive officer has described the organization as a supertanker, referring to scale — a portfolio approaching $800 billion — and the inability…

2025 Investment Innovation Conference: Central banks poised to increase investment allocations to gold

The outlier performance of investments in gold can be traced to risk-off activity from central banks around the world, according to Karlan Patel, vice-president and…

2025 Investment Innovation Conference: Journalist mindset expanding due diligence scope for institutional investors

Using journalistic-style investment due diligence can add a differentiated component to a multi-dimensional approach to research, according to Raphael Lewis, head of specialist research at…

2025 Investment Innovation Conference: Institutional investors relying on passive global equity strategies missing out on portable alpha

By separating a traditional active equity portfolio into two groups, institutional investors can gain resilience and add value at a time when active global equity…

2025 Investment Innovation Conference: Institutional investors creating internal guidelines for effective AI use

Institutional investors are responsible for setting guardrails and monitoring the use of artificial intelligence tools, rendering standardized guidelines unhelpful at the moment, according to Jacky…

2025 Investment Innovation Conference: How will AI impact the future of investment leadership?

Alongside deglobalization and changing global supply chains, technology is now permeating strategy at a global level, with artificial intelligence moving from a topic of innovation…

2025 Investment Innovation Conference: TTC Pension Plan CEO talks in-house expertise, diversification and opportunities in AI

Over the last 80 years, the TTC Pension Plan has grown from a contribution of $250,000 and a small team within the Toronto Transit Commission…

2025 Investment Innovation Conference: How can financial institutions prepare for financial distress amid rising geopolitical tensions?

While Canada’s financial system was fit for purpose across decades of liberal democratic order, it’s important to look at how the system should be structured…

Webinar coverage: Early diagnosis, high-efficacy treatments transforming life with MS

Canada has the highest rate of multiple sclerosis in the world, with an estimated 90,000 to 100,000 people living with the disease. Every day, 12…

Webinar coverage: New brain tumour treatment offers hope for working Canadians

Glioma, the most common malignant brain tumour in young adults under 50 is a devastating disease that often strikes people in their prime working years,…

Webinar coverage: New treatment marks a turning point in Alzheimer’s care

Health Canada recently approved the first disease-modifying therapy for Alzheimer’s disease, which is a long-awaited milestone that carries significant implications for private drug plans, employers…